Patents by Inventor Jason Wan

Jason Wan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEIN ESSENTIAL AMINO ACIDS FORMULATIONS FOR HUMAN NUTRITION
    Publication number: 20210282445
    Abstract: This invention covers protein essential amino acids formulations as dietary supplements, nutritional formulations and foods that provide balanced and adequate levels of essential amino acid compositions to meet the recommended nutritional requirements for humans of different age groups and special need groups.
    Type: Application
    Filed: March 11, 2020
    Publication date: September 16, 2021
    Inventors: Eric Jamie Wan, Jason Wan, Yang Chen
  • (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2-(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide compositions for pharmaceutical preparations
    Patent number: 10577348
    Abstract: A composition comprising (S)—N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide and hypromellose acetate succinate for pharmaceutical preparations, especially capsule preparations.
    Type: Grant
    Filed: December 14, 2015
    Date of Patent: March 3, 2020
    Assignee: MERCK SHARP & DOHME CORP.
    Inventors: Pranav Gupta, Jason Wan, Scott T. Trzaska
  • (S)-N-(3-(6-ISOPROPOXYPYRIDIN-3-YL)-1H-INDAZOL-5-YL)-1-(2-(4-(4-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3,6-DIHYDROPYRIDIN-1(2H)-YL)-2-OXOETHYL)-3-(METHYLTHIO)PYRROLIDINE-3-CARBOXAMIDE COMPOSITIONS FOR PHARMACEUTICAL PREPARATIONS
    Publication number: 20170362202
    Abstract: A composition comprising (S)-N-(3-(6-isopropoxypyridin-3-yl)-1H-indazol-5-yl)-1-(2(4-(4-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)-3,6-dihydropyridin-1(2H)-yl)-2-oxoethyl)-3-(methylthio)pyrrolidine-3-carboxamide and hypromellose acetate succinate for pharmaceutical preparations, especially capsule preparations.
    Type: Application
    Filed: December 14, 2015
    Publication date: December 21, 2017
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Pranav Gupta, Jason Wan, Scott T. Trzaska
  • Bacteriocin piscicolin 126
    Patent number: 6054163
    Abstract: The present invention provides a bacteriocin having a molecular weight of about 4.4 kDa and methods involving the use of this bacteriocin. The bacteriocin preferably has an amino acid sequence as shown in SEQ ID NO:5 (FIG. 3). The present invention also provides a DNA molecule encoding this bacteriocin.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: April 25, 2000
    Assignees: The University of Melbourne, Commonwealth Scientific and Industrial Research Organisation, Daratech Pty Limited
    Inventors: Richard Edward Hugh Wettenhall, Barrie Ernest Davidson, Alan James Hillier, Kim Harmark, Ralph Wilson Jack, Malcolm Wayne Hickey, John Coventry, Jason Wan